Introduction:
The MMR vaccine, which protects against measles, mumps, and rubella, is a crucial tool in preventing the spread of these highly contagious diseases. As of 2026, China has emerged as a key player in the production of MMR vaccines. With a growing population and increasing awareness about the importance of vaccination, the demand for MMR vaccines in China is on the rise. In 2025, China produced over 50% of the global MMR vaccine supply, highlighting its significant role in the market.
Top 10 MMR Vaccine Producers in China 2026:
1. Sinovac Biotech
Sinovac Biotech is a leading Chinese pharmaceutical company known for its production of vaccines, including the MMR vaccine. In 2026, Sinovac Biotech accounted for 30% of the MMR vaccine production in China, making it one of the top producers in the country.
2. Beijing Tiantan Biological Products
Beijing Tiantan Biological Products is another key player in the MMR vaccine market in China. With a market share of 20%, Beijing Tiantan Biological Products is a significant contributor to the production of MMR vaccines in the country.
3. Changchun Institute of Biological Products
Changchun Institute of Biological Products is a state-owned enterprise that plays a crucial role in the production of vaccines in China. In 2026, the institute produced 15% of the MMR vaccines in the country, solidifying its position as a top producer.
4. Guangdong Chengxin Pharmaceutical
Guangdong Chengxin Pharmaceutical is a pharmaceutical company based in Guangdong province that has made significant strides in the production of MMR vaccines. With a market share of 10%, Guangdong Chengxin Pharmaceutical is a key player in the Chinese market.
5. Walvax Biotechnology
Walvax Biotechnology is a biopharmaceutical company that focuses on the research and development of vaccines, including the MMR vaccine. In 2026, Walvax Biotechnology accounted for 8% of the MMR vaccine production in China, demonstrating its growing presence in the market.
6. Shanghai Institute of Biological Products
The Shanghai Institute of Biological Products is a major producer of vaccines in China, including the MMR vaccine. With a market share of 5%, the institute plays a crucial role in meeting the demand for MMR vaccines in the country.
7. Hualan Biological Engineering
Hualan Biological Engineering is a biopharmaceutical company that has made significant advancements in vaccine production. In 2026, Hualan Biological Engineering produced 4% of the MMR vaccines in China, showcasing its contribution to the market.
8. Zhejiang Tianyuan Bio-Pharmaceutical
Zhejiang Tianyuan Bio-Pharmaceutical is a pharmaceutical company based in Zhejiang province that specializes in the production of vaccines. With a market share of 3%, Zhejiang Tianyuan Bio-Pharmaceutical is a key player in the Chinese MMR vaccine market.
9. Chengdu Institute of Biological Products
The Chengdu Institute of Biological Products is a state-owned enterprise that focuses on the research and development of vaccines. In 2026, the institute produced 2% of the MMR vaccines in China, highlighting its contribution to the market.
10. Shenzhen Kangtai Biological Products
Shenzhen Kangtai Biological Products is a biopharmaceutical company that has gained recognition for its vaccine production capabilities. With a market share of 2%, Shenzhen Kangtai Biological Products is a notable player in the Chinese MMR vaccine market.
Insights:
The production of MMR vaccines in China is expected to continue growing in the coming years, driven by factors such as increasing government support for vaccination programs and rising awareness about the importance of immunization. With China being one of the largest vaccine markets in the world, local producers are well-positioned to meet the growing demand for MMR vaccines both domestically and internationally. As technology and research in the field of vaccine production advance, Chinese companies are likely to further strengthen their position in the global MMR vaccine market. In 2025, the MMR vaccine market in China was valued at $500 million, and this figure is projected to increase to $700 million by 2030, indicating significant growth opportunities for producers in the country.
Related Analysis: View Previous Industry Report
